Bisphenol A and 17β-estradiol promote arrhythmia in the female heart via alteration of calcium handling

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Yan, Sujuan ^a,b   Chen, Yamei ^a   Dong, Min ^a   Song, Weizhong ^a   Belcher, Scott M ^a   Wang, Hong Sheng ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b NANCHANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ESTRADIOL; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; ENDOCRINE DISRUPTOR; ESTROGEN; ESTROGEN RECEPTOR BETA; PHENOL DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARRHYTHMOGENESIS; ARTICLE; CALCIUM TRANSPORT; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; FEMALE; HEART MUSCLE CELL; HEART VENTRICLE ARRHYTHMIA; HORMONE ACTION; NONHUMAN; RAT; ANIMAL; CALCIUM SIGNALING; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; DRUG EFFECT; GENE INACTIVATION; GENETICS; HEART; HEART ARRHYTHMIA; HEART VENTRICLE; MALE; METABOLISM; MOUSE; PATHOLOGY; SARCOPLASMIC RETICULUM; SEXUAL DEVELOPMENT; TIME;

RATTUS; RODENTIA;

ANIMALS; ARRHYTHMIAS, CARDIAC; CALCIUM SIGNALING; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOCRINE DISRUPTORS; ESTRADIOL; ESTROGEN RECEPTOR BETA; ESTROGENS; FEMALE; GENE KNOCKOUT TECHNIQUES; HEART; HEART VENTRICLES; MALE; MICE; MYOCYTES, CARDIAC; PHENOLS; RATS; SARCOPLASMIC RETICULUM; SEX CHARACTERISTICS; TIME FACTORS;

EID: 80053201979     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025455     Document Type: Article

References (41)

1. Le HH, Carlson EM, Chua JP, Belcher SM, (2008) Bisphenol A is released from polycarbonate drinking bottles and mimics the neurotoxic actions of estrogen in developing cerebellar neurons. Toxicol Lett 176: 149-156.
2. Vandenberg LN, Chahoud I, Heindel JJ, Padmanabhan V, Paumgartten FJ, et al. (2010) Urinary, circulating, and tissue biomonitoring studies indicate widespread exposure to bisphenol A. Environ Health Perspect 118: 1055-1070.
3. Calafat AM, Kuklenyik Z, Reidy JA, Caudill SP, Ekong J, et al. (2005) Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population. Environ Health Perspect 113: 391-395.
4. Calafat AM, Ye X, Wong LY, Reidy JA, Needham LL, (2008) Exposure of the U.S. population to bisphenol A and 4-tertiary-octylphenol: 2003-2004. Environ Health Perspect 116: 39-44.
5. Dekant W, Volkel W, (2008) Human exposure to bisphenol A by biomonitoring: methods, results and assessment of environmental exposures. Toxicol Appl Pharmacol 228: 114-134.
6. Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, Hauser R, Prins GS, et al. (2009) Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr Rev 30: 293-342.
7. vom Saal FS, Cooke PS, Buchanan DL, Palanza P, Thayer KA, et al. (1998) A physiologically based approach to the study of bisphenol A and other estrogenic chemicals on the size of reproductive organs, daily sperm production, and behavior. Toxicol Ind Health 14: 239-260.
8. Richter CA, Birnbaum LS, Farabollini F, Newbold RR, Rubin BS, et al. (2007) In vivo effects of bisphenol A in laboratory rodent studies. Reprod Toxicol 24: 199-224.
9. Wetherill YB, Akingbemi BT, Kanno J, McLachlan JA, Nadal A, et al. (2007) In vitro molecular mechanisms of bisphenol A action. Reprod Toxicol 24: 178-198.
10. Lang IA, Galloway TS, Scarlett A, Henley WE, Depledge M, et al. (2008) Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA 300: 1303-1310.
11. Czubryt MP, Espira L, Lamoureux L, Abrenica B, (2006) The role of sex in cardiac function and disease. Can J Physiol Pharmacol 84: 93-109.
12. Babiker FA, De Windt LJ, van Eickels M, Grohe C, Meyer R, et al. (2002) Estrogenic hormone action in the heart: regulatory network and function. Cardiovasc Res 53: 709-719.
13. Mendelsohn ME, Karas RH, (2005) Molecular and cellular basis of cardiovascular gender differences. Science 308: 1583-1587.
14. Bhupathy P, Haines CD, Leinwand LA, (2010) Influence of sex hormones and phytoestrogens on heart disease in men and women. Womens Health (Lond Engl) 6: 77-95.
15. Du XJ, Fang L, Kiriazis H, (2006) Sex dimorphism in cardiac pathophysiology: experimental findings, hormonal mechanisms, and molecular mechanisms. Pharmacol Ther 111: 434-475.
16. Jiang C, Poole-Wilson PA, Sarrel PM, Mochizuki S, Collins P, et al. (1992) Effect of 17 beta-oestradiol on contraction, Ca2+ current and intracellular free Ca2+ in guinea-pig isolated cardiac myocytes. Br J Pharmacol 106: 739-745.
17. Meyer R, Linz KW, Surges R, Meinardus S, Vees J, et al. (1998) Rapid modulation of L-type calcium current by acutely applied oestrogens in isolated cardiac myocytes from human, guinea-pig and rat. Exp Physiol 83: 305-321.
18. Nakajima T, Iwasawa K, Oonuma H, Morita T, Goto A, et al. (1999) Antiarrhythmic effect and its underlying ionic mechanism of 17beta-estradiol in cardiac myocytes. Br J Pharmacol 127: 429-440.
19. Bers DM, (2008) Calcium cycling and signaling in cardiac myocytes. Annu Rev Physiol 70: 23-49.
20. Bers DM, (2002) Cardiac excitation-contraction coupling. Nature 415: 198-205.
21. Pogwizd SM, Bers DM, (2004) Cellular basis of triggered arrhythmias in heart failure. Trends Cardiovasc Med 14: 61-66.
22. Cheng H, Lederer WJ, Cannell MB, (1993) Calcium sparks: elementary events underlying excitation-contraction coupling in heart muscle. Science 262: 740-744.
23. Yuan Q, Fan GC, Dong M, Altschafl B, Diwan A, et al. (2007) Sarcoplasmic reticulum calcium overloading in junctin deficiency enhances cardiac contractility but increases ventricular automaticity. Circulation 115: 300-309.
24. Krege JH, Hodgin JB, Couse JF, Enmark E, Warner M, et al. (1998) Generation and reproductive phenotypes of mice lacking estrogen receptor beta. Proc Natl Acad Sci U S A 95: 15677-15682.
25. Wehrens XH, Lehnart SE, Marks AR, (2005) Ryanodine receptor-targeted anti-arrhythmic therapy. Ann N Y Acad Sci 1047: 366-375.
26. Marks AR, (2006) Novel therapy for heart failure and exercise-induced ventricular tachycardia based on 'fixing' the leak in ryanodine receptors. Novartis Found Symp 274: 132-147 discussion 147-155, 272-136.
27. Bers DM, Guo T, (2005) Calcium signaling in cardiac ventricular myocytes. Ann N Y Acad Sci 1047: 86-98.
28. Xing L, Xu Y, Xiao Y, Shang L, Liu R, et al. (2010) Embryotoxic and teratogenic effects of the combination of bisphenol A and genistein on in vitro cultured postimplantation rat embryos. Toxicol Sci 115: 577-588.
29. Xiao Y, Liu R, Xing L, Xu Y, Shang L, et al. (2011) Combined developmental toxicity of bisphenol A and genistein in micromass cultures of rat embryonic limb bud and midbrain cells. Toxicol In Vitro 25: 153-159.
30. Rajapakse N, Ong D, Kortenkamp A, (2001) Defining the impact of weakly estrogenic chemicals on the action of steroidal estrogens. Toxicol Sci 60: 296-304.
31. Silva E, Rajapakse N, Kortenkamp A, (2002) Something from "nothing"--eight weak estrogenic chemicals combined at concentrations below NOECs produce significant mixture effects. Environ Sci Technol 36: 1751-1756.
32. Zsarnovszky A, Le HH, Wang HS, Belcher SM, (2005) Ontogeny of rapid estrogen-mediated extracellular signal-regulated kinase signaling in the rat cerebellar cortex: potent nongenomic agonist and endocrine disrupting activity of the xenoestrogen bisphenol A. Endocrinology 146: 5388-5396.
33. Chung TH, Wang SM, Wu JC, (2004) 17beta-estradiol reduces the effect of metabolic inhibition on gap junction intercellular communication in rat cardiomyocytes via the estrogen receptor. J Mol Cell Cardiol 37: 1013-1022.
34. Arias-Loza PA, Jazbutyte V, Pelzer T, (2008) Genetic and pharmacologic strategies to determine the function of estrogen receptor alpha and estrogen receptor beta in cardiovascular system. Gend Med 5 (Suppl A): S34-45.
35. Le HH, Belcher SM, (2010) Rapid signaling actions of environmental estrogens in developing granule cell neurons are mediated by estrogen receptorβ. Endocrinology 151: 5689-5699.
36. Levin ER, (2008) Rapid signaling by steroid receptors. Am J Physiol Regul Integr Comp Physiol 295: R1425-1430.
37. Fu XD, Simoncini T, (2008) Extra-nuclear signaling of estrogen receptors. IUBMB Life 60: 502-510.
38. Wolbrette D, Naccarelli G, Curtis A, Lehmann M, Kadish A, (2002) Gender differences in arrhythmias. Clin Cardiol 25: 49-56.
39. Barakat K, Wilkinson P, Suliman A, Ranjadayalan K, Timmis A, (2000) Acute myocardial infarction in women: contribution of treatment variables to adverse outcome. Am Heart J 140: 740-746.
40. Yap YG, Duong T, Bland M, Malik M, Torp-Pedersen C, et al. (2005) Temporal trends on the risk of arrhythmic vs. non-arrhythmic deaths in high-risk patients after myocardial infarction: a combined analysis from multicentre trials. Eur Heart J 26: 1385-1393.
41. Forster C, Kietz S, Hultenby K, Warner M, Gustafsson JA, (2004) Characterization of the ERbeta-/-mouse heart. Proc Natl Acad Sci U S A 101: 14234-14239.